MINERALYS THERAPEUTICS INC (MLYS) Institutional Shareholders

MINERALYS THERAPEUTICS INC (MLYS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $2.64B in MLYS holdings during the latest filing period.

Catalys Pacific, Llc is currently the largest disclosed institutional shareholder of MLYS tracked by InsiderSet, reporting ownership valued at approximately $213.25M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $217.67M, representing an estimated gain of +2.08% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 49% of the total disclosed MLYS value among the investors covered in this analysis. Major shareholders include Catalys Pacific, Llc, Ra Capital Management, L.P., Blackrock, Inc., and several other long-term asset managers with concentrated positions in MINERALYS THERAPEUTICS INC (MLYS).

This page ranks the largest institutional MLYS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

217

Total Reported Value

$2.64B

Largest Holder

Catalys Pacific, Llc

Largest Position

$213.25M

Insider Transactions (90d)

16

Latest Filing Quarter

Q2 2026

New Institutional Positions

50

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Catalys Pacific, Llc92.94%7,903,838$213,245,549$217,671,699+$4,426,150+2.08%
Ra Capital Management, L.P.1.80%7,692,750$207,550,395$211,858,335+$4,307,940+2.08%
Blackrock, Inc.0.00%5,887,038$158,832,288$162,129,027+$3,296,739+2.08%
Samsara Biocapital, Llc13.01%5,871,018$158,400,066$161,687,836+$3,287,770+2.08%
Fmr Llc0.01%4,511,689$121,725,382$124,251,915+$2,526,533+2.08%
State Street Corp0.00%4,141,636$111,741,339$114,060,655+$2,319,316+2.08%
Deerfield Management Company, L.P.1.11%3,958,000$106,786,840$109,003,320+$2,216,480+2.08%
Vanguard Capital Management Llc0.00%2,756,770$74,377,655$75,921,446+$1,543,791+2.08%
Laurion Capital Management Lp4.90%2,506,152$67,615,981$69,019,426+$1,403,445+2.08%
Price T Rowe Associates Inc0.01%2,262,476$61,042,000$62,308,589+$1,266,589+2.07%
Orbimed Advisors Llc1.08%2,110,300$56,935,894$58,117,662+$1,181,768+2.08%
Capital World Investors0.01%1,997,607$53,895,437$55,014,097+$1,118,660+2.08%
Armistice Capital, Llc1.30%1,736,000$46,837,280$47,809,440+$972,160+2.08%
Troluce Capital Advisors Llc17.47%1,728,753$46,641,756$47,609,858+$968,102+2.08%
Andera Partners20.80%1,591,917$42,949,921$43,841,394+$891,473+2.08%
Geode Capital Management, Llc0.00%1,584,326$42,753,193$43,632,338+$879,145+2.06%
Sr One Capital Management, Lp4.06%1,563,966$42,195,803$43,071,624+$875,821+2.08%
Bank Of America Corp0.00%1,505,547$40,619,658$41,462,764+$843,106+2.08%
Sphera Funds Management Ltd.5.68%1,469,971$39,659,818$40,483,001+$823,183+2.08%
Goldman Sachs Group Inc0.00%1,458,676$39,355,079$40,171,937+$816,858+2.08%
Pictet Asset Management Holding Sa0.04%1,430,649$38,598,910$39,400,073+$801,163+2.08%
Polar Capital Holdings Plc0.11%1,420,854$38,334,641$39,130,319+$795,678+2.08%
Millennium Management Llc0.02%1,221,758$32,963,031$33,647,215+$684,184+2.08%
Ghisallo Capital Management Llc0.60%1,125,000$30,352,500$30,982,500+$630,000+2.08%
Invesco Ltd.0.00%1,091,180$29,440,036$30,051,097+$611,061+2.08%
Alliancebernstein L.P.0.01%1,067,541$28,919,686$29,400,079+$480,393+1.66%
Logos Global Management Lp1.22%1,050,000$28,329,000$28,917,000+$588,000+2.08%
American Century Companies Inc0.01%1,036,767$27,972,049$28,552,563+$580,514+2.08%
Morgan Stanley0.00%917,213$24,746,440$25,260,046+$513,606+2.08%
Davern Capital Partners, Lp3.95%858,753$23,169,156$23,650,058+$480,902+2.08%
Candriam S.C.A.0.10%857,037$23,100,611$23,602,799+$502,188+2.17%
Nantahala Capital Management, Llc1.34%820,481$22,136,577$22,596,047+$459,470+2.08%
Wellington Management Group Llp0.00%806,716$21,765,199$22,216,959+$451,760+2.08%
Affinity Asset Advisors, Llc0.99%750,000$20,235,000$20,655,000+$420,000+2.08%
Vanguard Portfolio Management Llc0.00%747,657$20,171,786$20,590,474+$418,688+2.08%
Tudor Investment Corp Et Al0.08%738,370$19,921,223$20,334,710+$413,487+2.08%
Aberdeen Group Plc0.03%689,235$18,595,560$18,981,532+$385,972+2.08%
Algert Global Llc0.21%649,027$17,510,748$17,874,204+$363,456+2.08%
Pale Fire Capital Se1.18%614,284$16,573,382$16,917,381+$343,999+2.08%
Stempoint Capital Lp2.81%602,686$16,260,468$16,597,972+$337,504+2.08%
Northern Trust Corp0.00%551,491$14,879,227$15,188,062+$308,835+2.08%
Charles Schwab Investment Management Inc0.00%521,216$14,062,408$14,354,289+$291,881+2.08%
Rock Springs Capital Management Lp0.64%484,951$13,083,978$13,355,551+$271,573+2.08%
Citadel Advisors Llc0.01%467,598$12,615,794$12,877,649+$261,855+2.08%
Dimensional Fund Advisors Lp0.00%463,387$12,501,914$12,761,678+$259,764+2.08%
Vanguard Fiduciary Trust Co0.00%450,370$12,150,983$12,403,190+$252,207+2.08%
Integral Health Asset Management, Llc0.50%450,000$12,141,000$12,393,000+$252,000+2.08%
Prosight Management, Lp2.09%449,795$12,135,469$12,387,354+$251,885+2.08%
Catalio Capital Management, Lp2.13%331,849$12,042,800$9,139,121-$2,903,679-24.11%
Rhenman & Partners Asset Management Ab1.06%416,371$11,233,690$11,466,857+$233,167+2.08%
Showing 50 of 217

Frequently asked questions about MLYS

  • Who owns the most MLYS stock?

    The largest holders of MLYS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for MINERALYS THERAPEUTICS INC (MLYS).

  • Is MLYS widely held by superinvestors?

    Many widely followed stocks like MLYS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly MLYS is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.